Ubtech Robotics: 13,000 Pre-Orders, 1,079 Deliveries, and a Stock That Won't Stop Falling
Published on 07/26/2026 at 06:03 | Redaktion boerse-global.de
The numbers coming out of Ubtech Robotics are the kind that usually send a stock soaring. The company has 13,000 pre-orders for its new U1 consumer humanoid robot, it just delivered a record 1,079 industrial humanoids in 2025, and its humanoid revenue surged more than 2,200% year-over-year. Yet the stock closed Friday at €8.73, down 5.84% on the day and just 1.5% above its 52-week low of €8.60. Since the start of 2025, the shares have cratered 39.37%.
That disconnect between operational milestones and market reception is the central puzzle facing investors. The answer, as both bulls and bears agree, hinges on one thing: whether Ubtech can actually turn those pre-orders into delivered products without destroying its margins.
The Execution Gap
Ubtech ended 2025 having delivered 1,079 humanoid industrial robots cumulatively — a figure it touts as a global first for any company exceeding the thousand-unit mark. That compares with just three units the year before, representing a staggering 35,800% increase in volume. The humanoid division generated 821 million yuan in revenue, up 2,203.7%, and now accounts for 41.1% of total group sales.
But the next leap is far larger. The company unveiled its U1 series in late June 2026, a line of hyperrealistic companion robots targeting China's mass market. Ubtech claims more than 13,000 pre-orders are already on the books. Production is slated to begin in mid-September 2026, and the ramp-up from 1,079 cumulative deliveries to over 13,000 units in a matter of months is what analysts are calling the "execution gap." Whether Ubtech can bridge it without quality issues or margin erosion will determine if the current share price weakness is an overreaction or a warning flag.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
Two Divergent Narratives
The bull case rests on first-mover advantage and a massive addressable market. The U1 series starts at roughly $17,000 for the "Lite" torso-only model and climbs to over $137,000 for the fully mobile "Ultra" version. The target demographic is vast: more than 100 million people in China living alone or as empty nesters. If even a fraction of the 13,000 pre-orders convert to paid deliveries starting in September, the revenue impact could fundamentally reshape Ubtech's financial profile.
The bear case points to the chart, which tells an unambiguous story. The stock now trades 31.64% below its 200-day moving average of €12.77, and the decline from the January high of €17.00 has been relentless. The technical complexity of the U1 — 88 degrees of freedom, ultra-bionic silicone skin, and a battery life of just two to four hours — raises the risk of production bottlenecks or costly warranty claims. At over $137,000 for the top-end model, mass-market adoption remains an open question.
Losses Narrow, But Cash Burn Continues
Ubtech's full-year 2025 results, released in late March, showed genuine operational improvement. The group's gross margin rose from 28.7% to 37.7%, driven by the shift toward higher-margin humanoid products. The net loss shrank 31.9% to 790 million yuan. For the humanoid division specifically, gross margin stood at 54.6%, implying an average selling price of roughly 760,000 yuan (about $110,593) per robot.
But the company remains deeply unprofitable, and its growth has been funded almost entirely through capital markets rather than operations. In 2025 alone, Ubtech issued new H-shares three times, raising approximately 5.78 billion yuan. The sixth and largest placement followed in November 2025, adding 3.11 billion Hong Kong dollars to the 4.37 billion Hong Kong dollars raised in five prior placements. Despite repeated dilution, the stock had more than doubled from the start of the year at the time of the November placement — gains that have since been completely erased.
Some of that fresh capital went straight out the door in December. Ubtech signed an agreement to acquire 43% of Fenglong Co., Ltd., a servomotor supplier, through a combination of share purchase and tender offer. The first tranche will bring its stake to 29.99%. Management frames the deal as vertical integration into the supply chain, not mere diversification.
The Competitive Landscape
Ubtech is not alone in the humanoid race. Competitor Unitree has already delivered more than 5,500 units globally, the highest volume of any company. Unitree's strategy is built on cheaper mass-market products, with its distribution cost ratio falling from 21% to 6.51% in just a few years. Ubtech has taken the opposite approach, targeting higher-priced industrial machines for factory use.
The divergence in strategy raises a critical question for Ubtech's long-term margin outlook. Can the company sustain an average selling price of 760,000 yuan per industrial robot as cheaper competition scales up? Or will pricing pressure force it lower, squeezing margins that are already insufficient to generate a profit?
Ubtech Robotics at a turning point? This analysis reveals what investors need to know now.
What's Next
Accounts receivable have ballooned from 913 million to 1.302 billion yuan over the past year, with Ubtech citing delayed payments from state-affiliated clients as a potential cash flow headwind. The relative strength index sits at 35.4, approaching oversold territory, but technical analysts caution that alone does not signal a bottom.
The next concrete catalyst is the U1 delivery launch in mid-September 2026. If Ubtech holds to its timeline and demonstrates credible progress in serial production, the €8.60 level could serve as a technical floor for speculative buyers. If production slips or the conversion rate of pre-orders to actual sales falls well short of 13,000 units, that support is likely to break.
Until then, the stock remains hostage to every piece of news about production capacity and order book transparency. The record delivery numbers are real. The question is whether they will ever translate into a record profit.
Ad
Ubtech Robotics Stock: New Analysis - 26 July
Fresh Ubtech Robotics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
